NRC Health
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $117.6M | $109.4M | $102.3M | $98.8M | $92.6M | $86.4M | $75.8M | $63.4M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $29.7M | $28.4M | $27.2M | $25.0M | $25.2M | $23.5M | $23.3M | $20.2M |
| Operating Income | $34.2M | $31.2M | $26.4M | $28.3M | $24.8M | $22.7M | $18.7M | $13.9M |
| Operating Margin | 29.1% | 28.5% | 25.8% | 28.6% | 26.8% | 26.3% | 24.7% | 21.9% |
| Interest Expense | $82.0K | $190.0K | $220.0K | $305.0K | $397.0K | $541.0K | $629.0K | $491.0K |
| Pretax Income | $34.3M | $31.4M | $27.4M | $28.1M | $24.5M | $22.2M | $18.2M | $13.3M |
| Income Tax Expense | $11.3M | $10.8M | $9.8M | $9.9M | $9.0M | $7.1M | $6.6M | $4.8M |
| Net Income | $22.9M | $20.5M | $17.6M | $18.2M | $15.5M | $15.1M | $11.6M | $11.6M |
| Net Margin | 19.5% | 18.8% | 17.2% | 18.4% | 16.7% | 17.4% | 15.3% | 18.2% |
| EPS (Basic) | — | — | — | — | — | $2.22 | $1.73 | $1.28 |
| EPS (Diluted) | — | — | — | — | — | $2.17 | $1.69 | $1.26 |
| Shares Outstanding (Basic) | 20.9M | — | — | — | 6.9M | 6.8M | 6.7M | 6.6M |
| Shares Outstanding (Diluted) | 20.9M | — | — | — | 6.9M | 7.0M | 6.8M | 6.7M |
| Dividends Per Share | — | — | — | — | — | $2.54 | $0.88 | $0.76 |